{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:08:43Z","timestamp":1761059323693},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T00:00:00Z","timestamp":1336089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00726-012-1307-x","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T03:02:34Z","timestamp":1336014154000},"page":"2293-2300","source":"Crossref","is-referenced-by-count":9,"title":["High clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease"],"prefix":"10.1007","volume":"43","author":[{"given":"B. V.","family":"Djordjevi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pavlovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"\u0106osi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Deljanin-Ili\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Risti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Krsti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Jevtovi\u0107-Stoimenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,4]]},"reference":[{"key":"1307_CR1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.amjcard.2004.11.023","volume":"95","author":"SW Bae","year":"2005","unstructured":"Bae SW, Stuhlinger MC, Yoo HS, Yu KH, Park HK, Choi BY et al (2005) Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Am J Cardiol 95:729\u2013733","journal-title":"Am J Cardiol"},{"key":"1307_CR2","first-page":"S784","volume":"120","author":"IO Blokhin","year":"2009","unstructured":"Blokhin IO, Stevens JW, Murry DJ, Galagudza MM, Shlyakhto EV, Leiper JM, Lentz SR (2009) Deficiency of dimethylarginine dimethylaminotransferase-1 exacerbates myocardial ischemia-reperfusion injury in mice. Circulation 120:S784","journal-title":"Circulation"},{"issue":"3","key":"1307_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00726-005-0268-8","volume":"30","author":"M Busch","year":"2006","unstructured":"Busch M, Fleck C, Wolf G, Stein G (2006) Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease-possible candidates for paradoxical epidemiology? Amino Acids 30(3):225\u2013232","journal-title":"Amino Acids"},{"issue":"9","key":"1307_CR4","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9149(02)02664-4","volume":"90","author":"JW Chen","year":"2002","unstructured":"Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS (2002) Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 90(9):974\u2013982","journal-title":"Am J Cardiol"},{"key":"1307_CR5","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.ATV.20.9.2032","volume":"20","author":"JP Cooke","year":"2000","unstructured":"Cooke JP (2000) Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20:2032\u20132037","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1307_CR6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.0000126823.07732.D5","volume":"109","author":"JP Cooke","year":"2004","unstructured":"Cooke JP (2004) Asymmetrical dimethylarginine: the Uber marker? Circulation 109:1813\u20131818","journal-title":"Circulation"},{"issue":"7 Pt 1","key":"1307_CR7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0895-7061(02)02278-1","volume":"15","author":"C Delles","year":"2002","unstructured":"Delles C, Schneider MP, John S, Gekle M, Schmieder RE (2002) Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension. Am J Hypertens 15(7 Pt 1):590\u2013593","journal-title":"Am J Hypertens"},{"issue":"8","key":"1307_CR8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1515\/CCLM.2008.213","volume":"46","author":"BV Djordjevi\u0107","year":"2008","unstructured":"Djordjevi\u0107 BV, Stojanovi\u0107 I, \u0106osi\u0107 V, Zvezdanovi\u0107 L, Deljanin-Ili\u0107 M, Dimi\u0107 S, Kundali\u0107 B, Cvetkovi\u0107 T, Jevtovi\u0107-Stoimenov T (2008) Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-\u03b1 levels in patients with ischemic heart disease. Clin Chem Lab Med 46(8):1149\u20131155","journal-title":"Clin Chem Lab Med"},{"key":"1307_CR9","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.2001.07817.x","volume":"78","author":"C Fleck","year":"2001","unstructured":"Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G (2001) Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int 78:S14\u2013S18","journal-title":"Kidney Int"},{"issue":"1\u20132","key":"1307_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(03)00338-3","volume":"336","author":"C Fleck","year":"2003","unstructured":"Fleck C, Schweitzer F, Karge E, Busch M, Stein G (2003) Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta 336(1\u20132):1\u201312","journal-title":"Clin Chim Acta"},{"key":"1307_CR11","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","volume":"16","author":"D Fliser","year":"2005","unstructured":"Fliser D, Kronenberg F, Kielstein JT et al (2005) Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol 16:2456\u20132461","journal-title":"J Am Soc Nephrol"},{"key":"1307_CR12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.CIR.102.1.118","volume":"102","author":"CW Hamm","year":"2000","unstructured":"Hamm CW, Braunwald E (2000) A classification of unstable angina revisited. Circulation 102:118\u2013122","journal-title":"Circulation"},{"issue":"8","key":"1307_CR13","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/00365510701429836","volume":"67","author":"GG Hov","year":"2007","unstructured":"Hov GG, Sagen E, Bigonah A, Asberg A (2007) Health-associated reference values for arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) measured with high-performance liquid chromatography. Scand J Clin Lab Invest 67(8):868\u2013876","journal-title":"Scand J Clin Lab Invest"},{"key":"1307_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2005.05.009","volume":"46","author":"JT Kielstein","year":"2005","unstructured":"Kielstein JT, Zoccali C (2005) Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 46:186\u2013202","journal-title":"Am J Kidney Dis"},{"key":"1307_CR15","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","volume":"21","author":"JT Kielstein","year":"2006","unstructured":"Kielstein JT, Salpeter SR, Bode-B\u00f6ger SM, Cooke JP, Fliser D (2006) Symmetric dimethylarginine (SDMA) as endogenous marker of renal function\u2014a meta-analysis. Nephrol Dial Transpl 21:2446\u20132451","journal-title":"Nephrol Dial Transpl"},{"key":"1307_CR16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/ATVBAHA.107.156596","volume":"28","author":"T Leong","year":"2008","unstructured":"Leong T, Zylberstein D, Graham I, Lissner L, Ward D, Fogarty J, Bengtsson C, Bjorkelund C, Thelle D (2008) Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women. 24-year follow up of the population study of women in Gothenburg. Arterioscler Thromb Vasc Biol 28:961\u2013967","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1307_CR17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cca.2007.07.006","volume":"384","author":"A Meinitzer","year":"2007","unstructured":"Meinitzer A, Puchinger M, Winklhofer-Roob BM, Rock E, Ribalta J, Roob JM, Sundl I, Halwachs-Baumann G, Marz W (2007) Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method. Clin Chim Acta 384:141\u2013148","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1307_CR18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2010.150854","volume":"57","author":"A Meinitzer","year":"2011","unstructured":"Meinitzer A, Keilstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO, Winkelmann BR, Marz W (2011) Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the ludwigshafen risk and cardiovascular health study. Clin Chem 57(1):112\u2013121","journal-title":"Clin Chem"},{"issue":"1","key":"1307_CR19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1054\/clnu.2002.0612","volume":"22","author":"RJ Nijveldt","year":"2003","unstructured":"Nijveldt RJ, Teerlink T, Siroen MP, van Lambalgen AA, Rauwerda JA, van Leeuwen PA (2003) The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 22(1):17\u201322","journal-title":"Clin Nutr"},{"issue":"2","key":"1307_CR20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00005344-200302000-00010","volume":"41","author":"H P\u00e4iv\u00e4","year":"2003","unstructured":"P\u00e4iv\u00e4 H, Laakso J, Lehtim\u00e4ki T, Isomustaj\u00e4rvi M, Ruokonen I, Laaksonen R (2003) Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors. J Cardiovasc Pharmacol 41(2):219\u2013222","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"1307_CR21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00726-005-0191-z","volume":"28","author":"R Paroni","year":"2005","unstructured":"Paroni R, Fermo I, Fiorina P, Cighetti G (2005) Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects. Amino Acids 28(4):389\u2013394","journal-title":"Amino Acids"},{"key":"1307_CR22","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","volume":"16","author":"P Ravani","year":"2005","unstructured":"Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C (2005) Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol 16:2449\u20132455","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"1307_CR23","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1021\/bi102022e","volume":"50","author":"HL Rust","year":"2011","unstructured":"Rust HL, Zurita-Lopez CI, Clarke S, Thompson PR (2011) Mechanistic studies on transcriptional coactivator protein arginine methyltransferase 1. Biochemistry 50(16):3332\u20133345","journal-title":"Biochemistry"},{"key":"1307_CR24","doi-asserted-by":"crossref","unstructured":"Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ, Goudeva L, Schmidt-Lucke C, Kusus M, Maas R, Schwedhelm E, Strodter D, Simon BC, Mugge A, Daniel WG, Tillmanns H, Maisch B, Streichert T, Boger RH (2006) Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J 152(3):493.e1\u2013e8","DOI":"10.1016\/j.ahj.2006.06.005"},{"issue":"2","key":"1307_CR25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.atherosclerosis.2009.06.039","volume":"208","author":"F Schulze","year":"2010","unstructured":"Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, Atzler D, Grant PJ, Boger RH (2010) Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis 208(2):518\u2013523","journal-title":"Atherosclerosis"},{"issue":"8","key":"1307_CR26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1373\/clinchem.2009.124263","volume":"55","author":"E Schwedhelm","year":"2009","unstructured":"Schwedhelm E, Xanthakis V, Maas R, Sullivan LM, Schulze F, Riederer U, Benndorf RA, Boger RH, Vasan RS (2009) Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort. Clin Chem 55(8):1539\u20131545","journal-title":"Clin Chem"},{"key":"1307_CR27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1475-2840-8-27","volume":"8","author":"L Sibal","year":"2009","unstructured":"Sibal L, Agarwal SC, Schwedhelm E, Luneburg N, Boger RH, Home PD (2009) A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria. Cardiovasc Diabetol 8:27","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1307_CR28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157340310791162659","volume":"6","author":"L Sibal","year":"2010","unstructured":"Sibal L, Agarwal SC, Home PD, Boger RH (2010) The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev 6(2):82\u201390","journal-title":"Curr Cardiol Rev"},{"key":"1307_CR29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardiores.2007.04.030","volume":"75","author":"MC Stuhlinger","year":"2007","unstructured":"Stuhlinger MC, Conci E, Haubner BJ, Stocker E-M, Schwaighofer J, Cooke JP, Tsao PS, Pachinger O, Metzler B (2007) Asymmetric dimethyl l-arginine (ADMA) is a critical regulator of myocardial reperfusion injury. Cardiovasc Res 75:417\u2013425","journal-title":"Cardiovasc Res"},{"key":"1307_CR30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199904000-00020","volume":"33","author":"A Surdacki","year":"1999","unstructured":"Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, Kruszelnicka-Kwiatkowska O, Kokot F, Dubiel JS, Froelich JC (1999) Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 33:652\u2013658","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"1307_CR31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/diacare.27.3.765","volume":"27","author":"L Tarnow","year":"2004","unstructured":"Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH (2004) Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. Diabetes Care 27(3):765\u2013769","journal-title":"Diabetes Care"},{"key":"1307_CR32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/abio.2001.5575","volume":"303","author":"T Teerlink","year":"2002","unstructured":"Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA (2002) Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303:131\u2013137","journal-title":"Anal Biochem"},{"key":"1307_CR33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1567-5688(03)00029-1","volume":"4","author":"VP Valkonen","year":"2003","unstructured":"Valkonen VP, Laakso J, Paiva H, Lehtimaki T, Lakka TA, Isomustajarvi M et al (2003) Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events. Does statin treatment influence plasma ADMA levels? Atheroscler Suppl 4:19\u201322","journal-title":"Atheroscler Suppl"},{"key":"1307_CR34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0195-668X(02)00618-8","volume":"24","author":"F Werf Van de","year":"2003","unstructured":"Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KAA et al (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 24:28\u201366","journal-title":"Eur Heart J"},{"issue":"6","key":"1307_CR35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jcp.54.6.470","volume":"54","author":"N Wahbi","year":"2001","unstructured":"Wahbi N, Dalton RN, Turner C, Denton M, Abbs I, Swaminathan R (2001) Dimethylarginines in chronic renal failure. J Clin Pathol 54(6):470\u2013473","journal-title":"J Clin Pathol"},{"issue":"4","key":"1307_CR36","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/jc.2004-1087","volume":"90","author":"S Ziegler","year":"2005","unstructured":"Ziegler S, Mittermayer F, Plank C, Minar E, Wolzt M, Schernthaner G-H (2005) Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease. J Clin Endocrinol Metabol 90(4):2175\u20132178","journal-title":"J Clin Endocrinol Metabol"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-012-1307-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-012-1307-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-012-1307-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T01:46:50Z","timestamp":1561686410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-012-1307-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,4]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1307"],"URL":"https:\/\/doi.org\/10.1007\/s00726-012-1307-x","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,4]]}}}